secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK:        0000949858
Form:       8-K
Filed at:   2023-03-06T23:59:59+00:00
Accession:  0001564590-23-003159
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Achieve Life Sciences enters cooperation agreement with Dialectic Capital; appoints three new directors
--------------------------------------------------------------------------------

- Company to appoint three Designees to Board by March 21, 2023, filling vacancies from incumbent departures or board expansion.
- Board size to be set at eight directors by 2023 Annual Meeting; incumbent directors may resign to comply.
- Dialectic agrees to standstill, voting commitments, and non-disparagement until Expiration Date (generally 15 business days before 2024 annual meeting).
- Designees to be nominated for election at 2023 Annual Meeting; at least one Designee on each committee except CMC.
- Agreement terminates if Dialectic ownership falls below 10% or material breach.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/949858/000156459023003159/0001564590-23-003159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/949858/000156459023003159/achv-8k_20230301.htm
  HTML page:      https://secwatch.observer/filing/0001564590-23-003159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer